Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabarun Dasgupta

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
North Carolina Medical Journal|July 11, 2022
History and Future of Harm Reduction in North Carolina: Pragmatism and InnovationNabarun Dasgupta
American Journal of Public Health|June 7, 2023
We Can't Arrest Our Way Out of Overdose: The Drug Bust ParadoxNabarun Dasgupta
Journal of Patient Experience|December 20, 2021
Countering Hesitancy and Misinformation on Side Effects to Complete the Course of COVID VaccinationNabarun Dasgupta
Drug Safety|March 5, 2021
Safety Consequences of Off-Label Drugs Used for COVID-19Nabarun Dasgupta
Addiction (Abingdon, England)|July 15, 2021
Commentary on Paljarvi et al: Can harder-to-crush oxycodone prevent overdose?Nabarun Dasgupta
American Journal of Public Health|July 27, 2021
Ghost in the Machine: The Emotional Gravity of Conducting Mortality ResearchNabarun Dasgupta
American Journal of Public Health|February 6, 2020
The Case for Product-Specific SurveillanceNabarun Dasgupta
American Journal of Public Health|August 9, 2018
"He Is the Object of Information": The Intersection of Big Data and the Opioid CrisisNabarun Dasgupta
The Lancet. Psychiatry|January 17, 2018
Evaluating difficult-to-crush opioids in the communityNabarun Dasgupta
American Journal of Public Health|July 15, 2020
Aligning Systems for HealthNabarun Dasgupta
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
North Carolina Medical Journal|July 11, 2022
History and Future of Harm Reduction in North Carolina: Pragmatism and InnovationNabarun Dasgupta
American Journal of Public Health|June 7, 2023
We Can't Arrest Our Way Out of Overdose: The Drug Bust ParadoxNabarun Dasgupta
Journal of Patient Experience|December 20, 2021
Countering Hesitancy and Misinformation on Side Effects to Complete the Course of COVID VaccinationNabarun Dasgupta
Drug Safety|March 5, 2021
Safety Consequences of Off-Label Drugs Used for COVID-19Nabarun Dasgupta
Addiction (Abingdon, England)|July 15, 2021
Commentary on Paljarvi et al: Can harder-to-crush oxycodone prevent overdose?Nabarun Dasgupta
American Journal of Public Health|July 27, 2021
Ghost in the Machine: The Emotional Gravity of Conducting Mortality ResearchNabarun Dasgupta
American Journal of Public Health|February 6, 2020
The Case for Product-Specific SurveillanceNabarun Dasgupta
American Journal of Public Health|August 9, 2018
"He Is the Object of Information": The Intersection of Big Data and the Opioid CrisisNabarun Dasgupta
The Lancet. Psychiatry|January 17, 2018
Evaluating difficult-to-crush opioids in the communityNabarun Dasgupta
American Journal of Public Health|July 15, 2020
Aligning Systems for HealthNabarun Dasgupta
Pageof 15